Studies have found that PDAC lacks CD8+T cell infiltration, and the high infiltration of myeloid suppressor cells and tumor-associated macrophages results in PDAC alone not being sensitive to anti-PD-L1 therapy. This evidence concerns the gene CD8A and neoplasm.